Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT.

Marie Robin,Junfeng Wang,Linda Koster,Dietrich W. Beelen,Martin Bornhäuser,Nicolaus Kroeger,Uwe Platzbecker,Jürgen Finke,Arnold Ganser,Didier Blaise,Fabio Ciceri,Johan Maertens,Hélène Labussière-Wallet,Patrice Chevallier,Jakob Passweg,Jan J. Cornelissen,Noel Milpied,Amandine Charbonnier,Francesca Bonifazi,Liesbeth C. de Wreede,Patrick Hayden,Christoph Scheid,Ibrahim Yakoub-Agha

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT.

2019

DISCLOSURES: Robin: Novartis Neovii: Research Funding. Beelen:Medac GmbH Wedel Germany: Consultancy, Honoraria. Kroeger:DKMS: Research Funding; Neovii: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Riemser: Research Funding; JAZZ: Honoraria; Sanofi-Aventis: Honoraria; Novartis: Honoraria, Research Funding; Medac: Honoraria. Platzbecker:Celgene: Consultancy, Honoraria, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Abbvie: Consultancy, Honoraria. Finke:Riemser: Honoraria, Other: research support, Speakers Bureau; Neovii: Honoraria, Other: research support, Speakers Bureau; Medac: Honoraria, Other: research support, Speakers Bureau. Blaise:Pierre Fabre medicaments: Honoraria; Molmed: Consultancy, Honoraria; Sanofi: Honoraria; Jazz Pharmaceuticals: Honoraria. Chevallier:Daiichi Sankyo: Honoraria; Incyte: Consultancy, Honoraria; Jazz Pharmaceuticals: Honoraria.

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations